Thus, high serum NfL concentrations may have been the result of comorbid diabetes mellitus (and possibly diabetic neuropathy) in this patient, and diabetes should be taken into account as confounding variable when applying neurofilaments as diagnostic biomarkers. This evidence concerns the gene NEFL and diabetic neuropathy.